Abhinav Jain
Director @ Prognoix
Abhinav Jain is a angel investor at Prognoix focused on Health Care and Therapeutics.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Abhinav Jain invests in
Stages Abhinav Jain invests in
Countries Abhinav Jain invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (50%)
- Therapeutics 1 (50%)
- Medical Device 1 (50%)
Stage
- Angel 1 (50%)
- Funding Round 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Prognoix
|
We believe digital technologies provide the best medium to deliver care for stigmatized illnesses. At Prognoix (pronounced prognoics), we are on a mission to help stigmatized illness patients by delivering science-based clinical care within the comfort and privacy of their homes. We develop low-risk digital and software medical devices that areinherently safe and based on established clinical guidelines. All our products are designed keeping clinicians and patients in mind.Our first product, Melonga, is a software medical device (CE mark class 1) for premature ejaculation, a highly stigmatized illness affecting 30% of all men. Please get in touch with us at hello@prognoix.com if you are interested in working with a multicultural team of clinicians and engineers to improve patients' lives. | $60K / Angel / Aug 01, 2020 | |
|
Prognoix
|
We believe digital technologies provide the best medium to deliver care for stigmatized illnesses. At Prognoix (pronounced prognoics), we are on a mission to help stigmatized illness patients by delivering science-based clinical care within the comfort and privacy of their homes. We develop low-risk digital and software medical devices that areinherently safe and based on established clinical guidelines. All our products are designed keeping clinicians and patients in mind.Our first product, Melonga, is a software medical device (CE mark class 1) for premature ejaculation, a highly stigmatized illness affecting 30% of all men. Please get in touch with us at hello@prognoix.com if you are interested in working with a multicultural team of clinicians and engineers to improve patients' lives. | $230K / May 11, 2018 |
About Prognoix
We believe digital technologies provide the best medium to deliver care for stigmatized illnesses. At Prognoix (pronounced prognoics), we are on a mission to help stigmatized illness patients by delivering science-based clinical care within the comfort and privacy of their homes. We develop low-risk digital and software medical devices that areinherently safe and based on established clinical guidelines. All our products are designed keeping clinicians and patients in mind.Our first product, Melonga, is a software medical device (CE mark class 1) for premature ejaculation, a highly stigmatized illness affecting 30% of all men. Please get in touch with us at hello@prognoix.com if you are interested in working with a multicultural team of clinicians and engineers to improve patients' lives.
Prognoix Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Abhinav Jain
Director
|
|||
|
Christoph Pies
Chief Medical Officer
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Abhinav Jain invest in?
Abhinav Jain invests primarily in Health Care, Therapeutics and Medical Device startups, most often at Angel and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Abhinav Jain?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Abhinav Jain last invest?
The most recent investment recorded for Abhinav Jain closed in Aug 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
